Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$699,557
+$57,311 QoQ
Shares Held
2,780
-5.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#2,871
of 4,150 holders
Holding Since
Dec 2023
11 quarters on record
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Main Street Group, LTD holds $2,042,882 across 10 Drug Manufacturers - General names. ABBV ranks #2 (34.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
3,455 | $877,465 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
2,780 | $699,557 | |
| 3 | LLY |
ELI LILLY & Co
|
142 | $170,319 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
818 | $103,346 | |
| 5 | AMGN |
Amgen Inc
|
245 | $88,718 | |
| 6 | MRK |
Merck & Co., Inc.
|
505 | $64,892 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
375 | $21,607 | |
| 8 | PFE |
Pfizer Inc
|
362 | $8,716 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $699,557 | 2,780 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $642,246 | 2,953 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $680,443 | 2,978 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $769,867 | 3,325 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $611,431 | 3,294 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $833,887 | 3,980 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $705,112 | 3,968 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $787,153 | 3,986 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $714,894 | 4,168 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $770,280 | 4,230 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $586,870 | 3,787 | Shares | Sole | 2024-02-15 | |
| No filing history on record for this holder in this stock. | ||||||